- DISTEFAR | Management of Clinical Trials
- 955 77 67 67
- info@distefar.com
24 June, 2022
In the framework of its General Assembly, held in Madrid Source: www.actasanitaria.com In the framework of its General Assembly, held in Madrid, Farmaindustria has highlighted, this […]
13 June, 2022
Representatives of patients’ associations, researchers and experts in health economics debate in the newspaper El Español on the link between health, the economy and the well-being […]
10 June, 2022
The digital transformation of biomedical research must be deployed with full safeguards for patients
The creation of the European Health Data Space is emerging as a great opportunity to boost R&D for new medicines. Public-private collaboration, once again, at the […]
9 June, 2022
For the first time in the history of medicine a drug completely kills all patients’ tumours Source: www.larazon.es It’s called dostarlimab, it’s an experimental cancer drug, […]
21 April, 2022
Farmaindustria’s self-regulation document is the focus of a scientific meeting organised by the Royal National Academy of Pharmacy. Source: www.farmaindustria.es Less than a month ago […]
22 March, 2022
Source: www.immedicohospitalario.es The Hospital Universitario Puerta de Hierro Majadahonda, led by the Head of the Medical Oncology Department, Dr. Mariano Provencio, is participating in an international […]
18 February, 2022
Source: www.immedicohospitalario.es Spanish researchers have just published a study that unravels the high intratumoural heterogeneity present in the different subtypes of endometrial cancer (serous and endometrioid) […]
14 February, 2022
Source: www.immedicohospitalario.es It is among the top 10 cancer research centres in the world and among the top two in Europe. Since its creation in 1998, […]
3 February, 2022
The new Clinical Trials Information System (CTIS), which centralizes processes with the aim of speeding up these studies, is now operational Source: www.actasanitaria.com With the entry […]
24 January, 2022
A report on the research pipeline of global pharmaceutical companies highlights the importance of this ‘first-in-class’ share for patients with unmet medical needs. It captures notable […]
13 December, 2021
More than 50% of the trials with new treatments are currently concentrated in Madrid and Barcelona Spain, a benchmark in clinical research, should also bet on […]
